부산대학교 도서관

Dupain C; Department of Drug Development and Innovation (D3i), Institut Curie, Paris, France.; Jacquin N; Department of Medical Oncology, Institut Curie, Paris, France.; Department of Medical Oncology, Institut Godinot, Reims, France.; Latouche A; INSERM U1331, Institut Curie, Saint-Cloud, France and Paris-Saclay University, Paris, France.; Conservatoire National des Arts et Metiers, Paris, France.; Nevière Z; Department of Medical Oncology, Centre François Baclesse, Caen, France.; Gestraud P; INSERM U1331, Curie CoreTech Bioinformatics (CUBIC), Institut Curie Research Center, Mines ParisTech, Paris, France.; Hamza A; Department of Genetics, Institut Curie, Paris, France.; INSERM U1016, CNRS UMR8104, Université Paris Cité, CARPEM, Institut Cochin, Paris, France.; Nedara K; Department of Drug Development and Innovation (D3i), Institut Curie, Paris, France.; Cockenpot V; Department of Pathology, Institut Curie, Paris, France.; Selves J; Department of Pathology, Institut Universitaire du Cancer Oncopole University Hospital of Toulouse, 31059, Toulouse, France.; Université Toulouse III-Paul Sabatier, F-31000, Toulouse, France.; Allory Y; Department of Pathology, Institut Curie, Paris, France.; Chanas L; Data Office, Institut Curie, Paris, France.; Milder M; Data Office, Institut Curie, Paris, France.; Soubeyran I; Department of Pathology, Institut Bergonié, Bordeaux, France.; Blons H; Institut du Cancer Paris Carpem, APHP Centre, Department of Biology, Pharmacogenomics and Molecular Oncology Unit, Hôpital Européen Georges Pompidou, Paris, France.; Patrikidou A; Department of Cancer Medicine, Gustave Roussy Cancer Center, Université Paris-Saclay, Villejuif, France.; de Bernardi A; Department of Medical Oncology, Centre Léon Bérard, Lyon, France.; Masliah-Planchon J; Department of Genetics, Institut Curie, Paris, France.; Mariani O; Center of Biological Ressources, Institut Curie, Paris, France.; Rouleau E; Biology and Pathology Department, Cancer Genetic Service, Gustave Roussy Cancer Center, U981, Université Paris-Saclay, Villejuif, France.; Escande F; CHRU Lille, Lille, France.; Boyault S; Department of Translationnal Research and Innovation, Centre de Recherche en Cancérologie de Lyon CRCL, INSERM U1052, CNRS UMR 5286, Centre Léon Bérard, UCBL1, Lyon, France.; Saintigny P; Department of Translationnal Research and Innovation, Centre de Recherche en Cancérologie de Lyon CRCL, INSERM U1052, CNRS UMR 5286, Centre Léon Bérard, UCBL1, Lyon, France.; de Fraipont F; CHU Grenoble, France.; Blanc P; Laboratoire SeqOIA, France.; Wong J; Department of Genetics, Institut Curie, Paris, France.; Tlemsani C; Department of Medical Oncology, Hôpital Cochin, APHP Centre, Université Paris Cité, Paris, France.; Guillou I; Department of Drug Development and Innovation (D3i), Institut Curie, Paris, France.; Flavius J; Department of Drug Development and Innovation (D3i), Institut Curie, Paris, France.; Fuentealba N; Department of Drug Development and Innovation (D3i), Institut Curie, Paris, France.; Kamal M; Department of Drug Development and Innovation (D3i), Institut Curie, Paris, France.; Bièche I; Department of Genetics, Institut Curie, Paris, France.; INSERM U1016, CNRS UMR8104, Université Paris Cité, CARPEM, Institut Cochin, Paris, France.; Servant N; INSERM U1331, Curie CoreTech Bioinformatics (CUBIC), Institut Curie Research Center, Mines ParisTech, Paris, France.; Le Tourneau C; Department of Drug Development and Innovation (D3i), Institut Curie, Paris, France.; INSERM U1331, Institut Curie, Saint-Cloud, France and Paris-Saclay University, Paris, France.; Watson S; Department of Medical Oncology, Institut Curie, Paris, France.; INSERM U1339 CNRS UMR3666, PSL Research University, Institut Curie Research Center, Paris, France.

Publisher: [Oxford] Country of Publication: England NLM ID: 101777707 Publication Model: eCollection Cited Medium: Internet ISSN: 2666-7762 (Electronic) Linking ISSN: 26667762 NLM ISO Abbreviation: Lancet Reg Health Eur Subsets: PubMed not MEDLINE

Séverine Chiesa; Natacha Naoun; Fanny Morin; Carine Da Fonseca; Gwladys Rousseau; Anna Patrikidou; Brice Fresneau; Benjamin Verret; Sarah Dumont; Lucy Metayer; Nathalie Gaspar

médecine/sciences. 41:676-682

Mathiot L; Drug Development Department, Gustave Roussy Cancer Campus, Villejuif Cedex, France.; Baldini C; Drug Development Department, Gustave Roussy Cancer Campus, Villejuif Cedex, France.; Letissier O; Drug Development Department, Gustave Roussy Cancer Campus, Villejuif Cedex, France.; Hollebecque A; Drug Development Department, Gustave Roussy Cancer Campus, Villejuif Cedex, France.; Bahleda R; Drug Development Department, Gustave Roussy Cancer Campus, Villejuif Cedex, France.; Gazzah A; Drug Development Department, Gustave Roussy Cancer Campus, Villejuif Cedex, France.; Smolenschi C; Drug Development Department, Gustave Roussy Cancer Campus, Villejuif Cedex, France.; Sakkal M; Drug Development Department, Gustave Roussy Cancer Campus, Villejuif Cedex, France.; Danlos FX; Drug Development Department, Gustave Roussy Cancer Campus, Villejuif Cedex, France.; Institut National de La Santé Et de La Recherche Médicale (INSERM) U1015, Villejuif, France.; Centre d'Investigations Cliniques Biothérapies Pour Une Immunisation in Situ (BIOTHERIS), INSERM, CIC1428, Villejuif, France.; Henon C; Drug Development Department, Gustave Roussy Cancer Campus, Villejuif Cedex, France.; Beshiri K; Drug Development Department, Gustave Roussy Cancer Campus, Villejuif Cedex, France.; Goldschmidt V; Drug Development Department, Gustave Roussy Cancer Campus, Villejuif Cedex, France.; Parisi C; Drug Development Department, Gustave Roussy Cancer Campus, Villejuif Cedex, France.; Patrikidou A; Drug Development Department, Gustave Roussy Cancer Campus, Villejuif Cedex, France.; Michot JM; Drug Development Department, Gustave Roussy Cancer Campus, Villejuif Cedex, France.; Marabelle A; Drug Development Department, Gustave Roussy Cancer Campus, Villejuif Cedex, France.; Postel-Vinay S; Drug Development Department, Gustave Roussy Cancer Campus, Villejuif Cedex, France.; Bernard-Tessier A; Drug Development Department, Gustave Roussy Cancer Campus, Villejuif Cedex, France.; Loriot Y; Drug Development Department, Gustave Roussy Cancer Campus, Villejuif Cedex, France.; Institut National de La Santé Et de La Recherche Médicale (INSERM) U981, Villejuif, France.; Ponce S; Drug Development Department, Gustave Roussy Cancer Campus, Villejuif Cedex, France.; Champiat S; Drug Development Department, Gustave Roussy Cancer Campus, Villejuif Cedex, France.; Institut National de La Santé Et de La Recherche Médicale (INSERM) U1015, Villejuif, France.; Centre d'Investigations Cliniques Biothérapies Pour Une Immunisation in Situ (BIOTHERIS), INSERM, CIC1428, Villejuif, France.; Ouali K; Drug Development Department, Gustave Roussy Cancer Campus, Villejuif Cedex, France. kaissa.ouali@gustaveroussy.fr.

Publisher: Current Science Country of Publication: United States NLM ID: 100888967 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-6269 (Electronic) Linking ISSN: 15233790 NLM ISO Abbreviation: Curr Oncol Rep Subsets: MEDLINE

Patrikidou, Anna; Oing, Christoph; Markellos, Christos; Heidenreich, Axel; Leao, Ricardo; Nicolai, Nicola; Boormans, Joost; Fischer, Stefanie; Fankhauser, Christian; Cazzaniga, Walter; Giannatempo, Patrizia; Berney, Daniel; Gremmels, Hendrik; Cornes, Robert; Janisch, Florian; Nardo, Domenico Di; Papachristofilou, Alexandros; Fizazi, Karim; Tandstad, Togrim; Nicol, David; Huddart, Robert

European Urology Oncology. 8(5):1248-1252

Grisay G; Department of Medical Oncology, Centres Hospitaliers Universitaires HELORA, La Louvière, Belgium.; Turco F; Oncology Institute of Southern Switzerland, Ente Ospedaliero Cantonale, Bellinzona, Switzerland.; Litiere S; Statistics Department, European Organization for Research and Treatment of Cancer (EORTC), Brussels, Belgium.; Fournier B; Medical Department, European Organization for Research and Treatment of Cancer (EORTC), Brussels, Belgium.; Patrikidou A; Genito-Urinary Oncology Group and Early Drug Development (DITEP), Gustave Roussy, Villejuif, France.; Gallardo E; Department of Oncology, Parc Taulí Hospital Universitari, Institut d'Investigació i Innovació Parc Taulí (I3PT-CERCA), Universitat Autònoma de Barcelona, Sabadell, Spain.; McDermott R; Department of Medical Oncology, St Vincents University Hospital and Cancer Trials, Dublin, Ireland.; Alanya A; Quality of Life Department, European Organization for Research and Treatment of Cancer (EORTC), Brussels, Belgium.; Gillessen S; Oncology Institute of Southern Switzerland, Ente Ospedaliero Cantonale, Bellinzona, Switzerland.; Faculty of Biomedical Sciences, Università della Svizzera Italiana, Lugano, Switzerland.; Tombal B; Division of Urology, Cliniques Universitaires Saint Luc, Brussels, Belgium.

Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE

Alice Bernard-Tessier; Natacha Naoun; Solenn Barraud; Ronan Flippot; Cedric Pobel; Macarena Rey; Capucine Baldini; Christophe Massard; Anna Patrikidou; Alina Fuerea; Mario Di Palma; Laurence Albigès; Yohann Loriot; Karim Fizazi

Ther Adv Med Oncol

Axel Heidenreich; Anna Patrikidou; Torgrim Tandstad

European Urology.

Flippot, Ronan; Telli, Tugce; Velev, Maud; Fléchon, Aude; De Vries-Brilland, Manon; Turpin, Léa; Bergman, Andries; Turco, Fabio; Mahammedi, Hakim; Fendler, Wolfgang; Giraudet, Anne-Laure; Josset, Quentin; Montravers, Françoise; Vogel, Wouter; Gillessen, Silke; Berardi Vilei, Simona; Herrmann, Ken; Kryza, David; Paone, Gaetano; Hadaschik, Boris; Merlin, Charles; Dufour, Pierre-Alban; Bernard-Tessier, Alice; Naoun, Natacha; Patrikidou, Anna; Garcia, Camilo; Foulon, Stéphanie; Pagès, Arnaud; Fizazi, Karim

European Urology Oncology. 7:1132-1140

Patrikidou A; Department of Medical Oncology and Early Drug Development Department, Gustave Roussy Institute, Villejuif, France.; Saieva C; Cancer Risk Factors and Lifestyle Epidemiology Unit-ISPRO, Florence, Italy.; Lee-Ying R; Tom Baker Cancer Centre, Calgary, Alberta, Canada.; Nuzzo PV; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY.; Zarif TE; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.; McClure H; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.; Davidsohn M; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.; Eid M; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.; Spinelli GP; Division of Medical Oncology, Casa della Salute di Aprilia, Latina, Sapienza University of Rome, Italy.; Catalano F; Medical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, Genova, Italy.; Cremante M; Medical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, Genova, Italy.; Fotia G; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.; Rossetti S; Instituto Nazionale Tumori IRCCS Fondazione G. Pascale, Naples, Italy.; Valenca L; Instituto D'Or de Pesquisa e Ensino, Salvador, Brazil.; Vauchier C; Department of Medical Oncology, Gustave Roussy Institute, Villejuif, France.; Ottanelli C; University of Florence, Florence, Italy.; Andrade L; Instituto D'Or de Pesquisa e Ensino, Salvador, Brazil.; Gennusa V; Department of Surgical, Oncological and Oral Sciences, Section of Medical Oncology, University of Palermo, Palermo, Italy.; Mestre RP; Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.; Fornarini G; Medical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, Genova, Italy.; Pignata S; Instituto Nazionale Tumori IRCCS Fondazione G. Pascale, Naples, Italy.; Procopio G; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.; Santini D; Oncology Unit, Umberto I hospital, Rome, Italy.; Ravi P; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.; Sweeney C; South Australian Immunogenomics Cancer Institute, University of Adelaide, Adelaide, Australia.; Heng D; Tom Baker Cancer Centre, Calgary, Alberta, Canada.; De Giorgi U; IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST), Meldola, Italy.; Fizazi K; Department of Medical Oncology, Gustave Roussy Institute, Villejuif, France.; Russo A; Department of Surgical, Oncological and Oral Sciences, Section of Medical Oncology, University of Palermo, Palermo, Italy.; Francini E; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy. Electronic address: edoardo.francini@unifi.it.

Publisher: Elsevier Country of Publication: United States NLM ID: 101260955 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0682 (Electronic) Linking ISSN: 15587673 NLM ISO Abbreviation: Clin Genitourin Cancer Subsets: MEDLINE

Ludovic Bigot; Jonathan Sabio; Loic Poiraudeau; Maxime Annereau; Naoual Menssouri; Carole Helissey; Olivier Déas; Marine Aglave; Tony Ibrahim; Cédric Pobel; Catline Nobre; Claudio Nicotra; Maud Ngo-Camus; Ludovic Lacroix; Etienne Rouleau; Lambros Tselikas; Jean-Gabriel Judde; Anne Chauchereau; Alice Bernard-Tessier; Anna Patrikidou; Natacha Naoun; Ronan Flippot; Emeline Colomba; Alina Fuerea; Laurence Albiges; Pernelle Lavaud; Christophe Massard; Luc Friboulet; Karim Fizazi; Benjamin Besse; Jean-Yves Scoazec; Yohann Loriot

European Urology Oncology. 7:527-536

Fotia G; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; Saieva C; Cancer Risk Factors and Lifestyle Epidemiology Unit - ISPRO, Florence, Italy.; Lee-Ying R; Department of Oncology, University of Calgary Tom Baker Cancer Centre, Tom Baker Cancer Centre, Calgary, Alberta, Canada.; Patrikidou A; Department of Medical Oncology, Gustave Roussy Institute, Villejuif, France.; Nuzzo PV; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY.; Zanardi E; Medical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, Genova, Italy.; Rossetti S; IRCCS Istituto Nazionale dei Tumori Fondazione G. Pascale, Naples, Italy.; Davidsohn M; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.; Eid M; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.; El Zarif T; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.; McClure H; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.; Spinelli GP; Division of Medical Oncology, Casa della Salute di Aprilia, Latina, Sapienza University of Rome, Italy.; Damassi A; Medical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, Genova, Italy.; Murianni V; Medical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, Genova, Italy.; Vauchier C; Department of Medical Oncology, Gustave Roussy Institute, Villejuif, France.; Oliveira TM; Instituto D'Or de Pesquisa e Ensino, Salvador, Brazil.; Malgeri A; Fondazione Policlinico Campus Bio-Medico di Roma, Rome, Italy.; Modesti M; Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.; Mestre RP; Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.; Valenca L; Instituto D'Or de Pesquisa e Ensino, Salvador, Brazil.; Ravi P; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.; Santini D; Oncology Unit, Umberto I hospital, Rome, Italy.; Pignata S; IRCCS Istituto Nazionale dei Tumori Fondazione G. Pascale, Naples, Italy.; De Giorgi U; IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) Dino Amadori, Meldola, Italy.; Sweeney C; South Australian Immunogenomics Cancer Institute, University of Adelaide, Adelaide, Australia.; Heng D; Department of Oncology, University of Calgary Tom Baker Cancer Centre, Tom Baker Cancer Centre, Calgary, Alberta, Canada.; Procopio G; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; Russo A; Department of Surgical, Oncological and Oral Sciences, Section of Medical Oncology, University of Palermo, Palermo, Italy.; Francini E; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy. Electronic address: edoardo.francini@unifi.it.

Publisher: Elsevier Country of Publication: United States NLM ID: 101260955 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0682 (Electronic) Linking ISSN: 15587673 NLM ISO Abbreviation: Clin Genitourin Cancer Subsets: MEDLINE

Duval, Lucile ; Allignet, Benoît ; Chevreau, Christine ; Gravis, Gwenaelle ; Mazza, Camille ; Gross-Goupil, Marine ; Laguerre, Brigitte ; Peyrat, Patrice ; Izarn, Floriane ; Patrikidou, Anna ; Fléchon, Aude

In Clinical Genitourinary Cancer April 2025 23(2)

d'Abrigeon, C.; Ouali, K.; Herbel, N.; Champiat, S.; Hollebecque, A.; Smolenschi, C.; Sakkal, M.; Bahleda, R.; Gazzah, A.; Patrikidou, A.; Michot, J-M.; Hueso, T.; Ammari, S.; Loriot, Y.; Massard, C.P.; Bernard-Tessier, A.; Texier, M.; Baldini, C.

ESMO Open. 10

Anna, Patrikidou; Walter, Cazzaniga; Daniel, Berney; Joost, Boormans; Isabel, de Angst; Domenico, Di Nardo; Christian, Fankhauser; Stefanie, Fischer; Carmen, Gravina; Hendrik, Gremmels; Axel, Heidenreich; Florian, Janisch; Ricardo, Leão; Nicola, Nicolai; Christoph, Oing; Jan, Oldenburg; Robert, Shepherd; Torgrim, Tandstad; David, Nicol

European Urology. 84:289-301

Patrikidou A; Department of Medical Oncology, Gustave Roussy Institute, Paris Saclay University, 114 rue Edouard Vaillant, Villejuif, 94800, FranceUCL Cancer Institute & University College London Hospital, London, United Kingdom.; Zilli T; Department of Radiation Oncology, Geneva University Hospital and Faculty of Medicine, Geneva University, Geneva, Switzerland.; Baciarello G; Istituto Nazionale dei Tumori, Milan, Italy.; Terisse S; Department of Medical Oncology, Saint Louis Hospital, Paris, France.; Hamilou Z; Centre Hospitalier de l'Université de Montréal, Montreal, QC, Canada.; Fizazi K; Department of Medical Oncology, Gustave Roussy Institute, Paris Saclay University, 114 rue Edouard Vaillant, Villejuif, 94800, France.

Publisher: Sage Country of Publication: England NLM ID: 101510808 Publication Model: eCollection Cited Medium: Print ISSN: 1758-8340 (Print) Linking ISSN: 17588340 NLM ISO Abbreviation: Ther Adv Med Oncol Subsets: PubMed not MEDLINE

d'Abrigeon, C.; Ouali, K.; Herbel, N.; Champiat, S.; Hollebecque, A.; Smolenschi, C.; Sakkal, M.; Bahleda, R.; Gazzah, A.; Patrikidou, A.; Michot, J-M.; Hueso, T.; Ammari, S.; Loriot, Y.; Massard, C.P.; Bernard-Tessier, A.; Texier, M.; Baldini, C.

Immuno-Oncology and Technology. 24

Menssouri, Naoual; Poiraudeau, Loïc; Helissey, Carole; Bigot, Ludovic; Sabio, Jonathan; Ibrahim, Tony; Pobel, Cédric; Nicotra, Claudio; Ngo-Camus, Maud; Lacroix, Ludovic; Rouleau, Etienne; Tselikas, Lambros; Chauchereau, Anne; Blanc-Durand, Félix; Bernard-Tessier, Alice; Patrikidou, Anna; Naoun, Natacha; Flippot, Ronan; Colomba, Emeline; Fuerea, Alina; Albiges, Laurence; Lavaud, Pernelle; van de Wiel, Paul; den Biezen, Eveline; Wesseling-Rozendaal, Yvonne; Ponce, Santiago; Michiels, Stefan; Massard, Christophe; Gautheret, Daniel; Barlesi, Fabrice; André, Fabrice; Besse, Benjamin; Scoazec, Jean-Yves; Friboulet, Luc; Fizazi, Karim; Loriot, Yohann

Clinical Cancer Research. 29:4504-4517

Oing C; Rescigno P; Paffenholz P; Heinzelbecker J; Patrikidou A; Matulewicz RS; Huddart R

European Urology Focus. 10:361-363

Butt SU; Drug Development Unit, Sarah Cannon Research Institute, 93 Harley Street, London, W1G 6AD, UK. dr.s.butt01@gmail.com.; Guy's and St. Thomas' Hospital, Great Maze Pond, London, SE1 9RT, UK. dr.s.butt01@gmail.com.; Mejias A; Hospital Universitario Virgen del Rocio, Seville, Spain.; Morelli C; Tor Vergata University of Rome, Viale Oxford 81, 00133, Rome, RM, Italy.; Torga G; Drug Development Unit, Sarah Cannon Research Institute, 93 Harley Street, London, W1G 6AD, UK.; Happe M; School of Medicine, University of Cologne, Joseph-Stelzmann-Straße 20, 50931, Cologne, Germany.; Patrikidou A; Drug Development Unit, Sarah Cannon Research Institute, 93 Harley Street, London, W1G 6AD, UK.; University College London, London, NW1 2BU, UK.; Arkenau HT; Drug Development Unit, Sarah Cannon Research Institute, 93 Harley Street, London, W1G 6AD, UK.; University College London, London, NW1 2BU, UK.

Publisher: Springer Verlag Country of Publication: Germany NLM ID: 7806519 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0843 (Electronic) Linking ISSN: 03445704 NLM ISO Abbreviation: Cancer Chemother Pharmacol Subsets: MEDLINE

Morelli, Cristina; Formica, Vincenzo; Patrikidou, Anna; Rofei, Michela; Shiu, Kai Keen; Riondino, Silvia; Argirò, Renato; Floris, Roberto; Ferlosio, Amedeo; Orlandi, Augusto; Roselli, Mario; Arkenau, Hendrik-Tobias

J Gastrointest Oncol